Shanghai Haoyuan Pharmaceutical, 0.2% 28nov2030, CNY (Conv.)
Obligacje, Zmienne oprocentowanie, Zamienne
Obligacje, Zmienne oprocentowanie, Zamienne
|
Shanghai Haoyuan Pharmaceutical Co., Ltd., established in 2006 and listed on the STAR Market (stock code: 688131), is primarily engaged in providing CRO and CDMO services for small molecule and novel drug modalities to the global ...
Shanghai Haoyuan Pharmaceutical Co., Ltd., established in 2006 and listed on the STAR Market (stock code: 688131), is primarily engaged in providing CRO and CDMO services for small molecule and novel drug modalities to the global pharmaceutical and biotech industry. The company specializes in research, development, and production of pharmaceutical building blocks, intermediates, APIs, and formulations with an integrated service platform covering the entire drug development process.
|
| Step-up/Step-down |
|
|
|
|
|
|
|
|
Poznaj najbardziej kompletną bazę danych
1 000 000
obligacje
80 234
akcje
175 910
ETF & Funds
80 000
indeksów
Najskuteczniej kontroluj swój portfel